Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

RADAR Trial - Randomised Androgen Deprivation and Radiotherapy

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
National Health and Medical Research Council, Australia
Hunter Medical Research Institute (HMRI)
Health Research Council, New Zealand
Abbott
Novartis Pharmaceuticals
Cancer Society of New Zealand
University of Newcastle, Australia
Radiation Oncology, Calvary Mater Newcastle, Australia
Information provided by (Responsible Party):
Trans-Tasman Radiation Oncology Group (TROG)
ClinicalTrials.gov Identifier:
NCT00193856
First received: September 12, 2005
Last updated: November 18, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2018
  Estimated Primary Completion Date: August 2017 (Final data collection date for primary outcome measure)
Publications:
Haworth A, Kearvell R, Greer PB, Hooton B, Denham JW, Lamb D, Duchesne G, Murray J, Joseph D. Assuring high quality treatment delivery in clinical trials - Results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy study. Radiotherapy and Oncology 90 (2009) 299-306

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):